Age at menarche relates to depression in adolescent girls: Comparing a clinical sample to the general pediatric population.
Adolescence
Age at menarche
Depression
Estradiol
Puberty
Testosterone
Journal
Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073
Informations de publication
Date de publication:
01 12 2022
01 12 2022
Historique:
received:
27
03
2022
revised:
23
08
2022
accepted:
25
08
2022
pubmed:
5
9
2022
medline:
30
9
2022
entrez:
4
9
2022
Statut:
ppublish
Résumé
The timing of puberty, physical features of pubertal development, and hormones are closely intertwined but may also individually contribute to the risk for depression and depression severity. Additionally, their effects on mood may depend on depression severity, but previously this has only been studied in mostly subclinical depression. In 184 girls from a single psychiatric hospital with significant depressive symptoms (Beck Depression Inventory-II score > 13), the relationship between depression severity and age at menarche (AAM), pubertal status, and gonadal/adrenal hormones (estradiol, progesterone, DHEA-S, androstenedione, testosterone, dihydrotestosterone) was investigated. Moreover, AAM in depressed girls was compared to that from a representative sample of German adolescents without a psychiatric disorder (N = 1674). Androgen levels were compared to those of age- and sex-matched controls (N = 59). AAM but not pubertal stage or biochemical parameters related to depression. Girls with AAM at the lower normative range of pubertal development were 61 % more likely to develop depression and scored 4.9 points higher on the depression scale than girls experiencing menarche at the population average. Androstenedione levels were increased in the psychiatric sample, but neither androgen nor gonadal hormone levels were associated with depression severity. The study is cross-sectional. These observations confirm previous studies in mostly subclinical depression and highlight the importance of AAM for adolescent depression. Thus, AAM could be considered a prognostic factor for a clinical risk score assessing the probability of adolescent depression. Moreover, these findings suggest fostering efforts that address risk factors that contribute to an earlier AAM.
Identifiants
pubmed: 36058357
pii: S0165-0327(22)00948-X
doi: 10.1016/j.jad.2022.08.092
pii:
doi:
Substances chimiques
Androgens
0
Dihydrotestosterone
08J2K08A3Y
Testosterone
3XMK78S47O
Androstenedione
409J2J96VR
Progesterone
4G7DS2Q64Y
Estradiol
4TI98Z838E
Dehydroepiandrosterone Sulfate
57B09Q7FJR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103-112Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest The authors declare no conflicts of interest.